100 related articles for article (PubMed ID: 11860149)
1. An analysis of the mechanism by which cetiedil inhibits sickling.
Abu-Salah KM; Gambo AH
Life Sci; 2002 Jan; 70(9):1003-11. PubMed ID: 11860149
[TBL] [Abstract][Full Text] [Related]
2. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
Berkowitz LR; Orringer EP
Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
[TBL] [Abstract][Full Text] [Related]
3. An explanation for the efficacy of procaine in the treatment of sickle cell anaemia.
Abu-Salah KM; Gambo AH
Int J Biochem Cell Biol; 2005 Apr; 37(4):835-41. PubMed ID: 15694842
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of erythrocyte calcium transport by cetiedil.
Levine SN; Berkowitz LR; Orringer EP
Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
[TBL] [Abstract][Full Text] [Related]
5. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
Berkowitz LR; Orringer EP
J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
[TBL] [Abstract][Full Text] [Related]
6. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
[TBL] [Abstract][Full Text] [Related]
7. The effect of cetiedil on red cell membrane permeability.
Schmidt WF; Asakura T; Schwartz E
Blood Cells; 1982; 8(2):289-98. PubMed ID: 7159753
[TBL] [Abstract][Full Text] [Related]
8. Effect of cetiedil on cation and water movements in erythrocytes.
Schmidt WF; Asakura T; Schwartz E
J Clin Invest; 1982 Mar; 69(3):589-94. PubMed ID: 7061704
[TBL] [Abstract][Full Text] [Related]
9. Cetiedil inhibition of calmodulin-stimulated enzyme activity.
Levine SN; Berkowitz LR; Orringer EP
Biochem Pharmacol; 1984 Feb; 33(4):581-4. PubMed ID: 6231031
[TBL] [Abstract][Full Text] [Related]
10. The effects of cetiedil and its congeners on levcromakalim-stimulated 86Rb efflux from smooth and skeletal muscle.
Benton DC
Eur J Pharmacol; 1996 Dec; 317(2-3):329-33. PubMed ID: 8997618
[TBL] [Abstract][Full Text] [Related]
11. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.
Benton DC; Roxburgh CJ; Ganellin CR; Shiner MA; Jenkinson DH
Br J Pharmacol; 1999 Jan; 126(1):169-78. PubMed ID: 10051133
[TBL] [Abstract][Full Text] [Related]
12. The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil.
Roxburgh CJ; Ganellin CR; Shiner MA; Benton DC; Dunn PM; Ayalew Y; Jenkinson DH
J Pharm Pharmacol; 1996 Aug; 48(8):851-7. PubMed ID: 8887737
[TBL] [Abstract][Full Text] [Related]
13. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
Stuart J; Stone PC; Bilto YY; Keidan AJ
J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of erythrocyte membrane ATPases with antisickling and anaesthetic substances and ionophoric antibiotics.
Abu-Salah KM
Life Sci; 1996; 58(3):187-93. PubMed ID: 9499159
[TBL] [Abstract][Full Text] [Related]
15. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
Agre P; Virshup D; Bennett V
J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
[TBL] [Abstract][Full Text] [Related]
16. Cetiedil-induced increase in water exchange in sickle cell anemia erythrocytes.
Narasimhan C; Fung LW
J Pharm Sci; 1991 Nov; 80(11):1101-2. PubMed ID: 1815064
[No Abstract] [Full Text] [Related]
17. Molecular properties of cetiedil and its interactions with erythrocyte membranes.
Narasimhan C; Fung LW
J Pharm Sci; 1986 Jul; 75(7):654-9. PubMed ID: 3020225
[TBL] [Abstract][Full Text] [Related]
18. Influence of cetiedil on erythrocyte membrane microviscosity and acetylcholinesterase activity.
Giannettini J; Chauvet M; Dell'Amico M; Bourdeaux M
Pharmacol Res; 1992 Jan; 25(1):31-41. PubMed ID: 1738756
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the mechanism by which cetiedil inhibits the Gardos phenomenon.
Berkowitz LR; Orringer EP
Am J Hematol; 1984 Oct; 17(3):217-23. PubMed ID: 6475933
[TBL] [Abstract][Full Text] [Related]
20. Effects of cetiedil on the oxidative metabolism of activated polymorphonuclear leucocytes.
Kohzaki H; Kakinuma K; Asakura T; Yamakawa T
Br J Haematol; 1985 Jul; 60(3):531-9. PubMed ID: 4015989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
